📷 Image: Wikimedia Commons / Arjunaraoc
Health
Supreme Court orders Andhra High Court to monitor probe into 7‑year‑old's death after anti‑malaria dose
✍️ The Indian Express
🗓 06 Oct 2026, 04:31 AM
👁 7
A seven‑year‑old child died in Andhra Pradesh after receiving an anti‑malaria medication. The Supreme Court has directed the state High Court to closely supervise the investigation.
A seven‑year‑old child in Andhra Pradesh succumbed after being administered an anti‑malaria drug, prompting a legal and medical outcry. The incident has raised concerns about prescription practices and drug safety in the state.
Following the child's death, the Supreme Court of India intervened, instructing the Andhra Pradesh High Court to take charge of monitoring the ongoing probe. The apex court emphasized the need for a transparent, time‑bound inquiry to determine whether medical negligence or procedural lapses contributed to the fatal outcome.
State health officials have been asked to cooperate fully with the High Court-appointed oversight team, providing all medical records, drug procurement details, and testimonies from treating physicians. The court's directive aims to ensure accountability and prevent similar tragedies in the future.
The investigation will also examine the supply chain of the anti‑malaria medication, including its dosage guidelines and distribution channels, to verify compliance with national drug safety standards. Families of the deceased child and other affected parties have been urged to submit any relevant information to aid the inquiry.
The Supreme Court's order underscores the judiciary's role in safeguarding public health and reinforces the imperative for stringent monitoring of drug administration practices across India.
Following the child's death, the Supreme Court of India intervened, instructing the Andhra Pradesh High Court to take charge of monitoring the ongoing probe. The apex court emphasized the need for a transparent, time‑bound inquiry to determine whether medical negligence or procedural lapses contributed to the fatal outcome.
State health officials have been asked to cooperate fully with the High Court-appointed oversight team, providing all medical records, drug procurement details, and testimonies from treating physicians. The court's directive aims to ensure accountability and prevent similar tragedies in the future.
The investigation will also examine the supply chain of the anti‑malaria medication, including its dosage guidelines and distribution channels, to verify compliance with national drug safety standards. Families of the deceased child and other affected parties have been urged to submit any relevant information to aid the inquiry.
The Supreme Court's order underscores the judiciary's role in safeguarding public health and reinforces the imperative for stringent monitoring of drug administration practices across India.